Skip to main content

Table 2 Intraoperative and postoperative data of patients in each group

From: Clinical outcome of a branch-first approach with a novel continuous whole-brain perfusion strategy for total arch surgery

Items

u-ACP group (N = 18)

n-WBP group (N = 12)

t/Z-values

P-values

Intraoperative information

    

Cerebral oxygenation during cerebral perfusion (%, mean ± SD)

64.94 ± 1.73

65.58 ± 1.17

-1.12

0.273

Minimum nasopharyngeal temperature [℃, median (IQR)]

27.10 (2.20)

26.30 (1.10)

-0.89

0.373

CPB duration (min, mean ± SD)

234.83 ± 36.29

196.17 ± 12.06

-3.37

< 0.001

ACC duration (min, mean ± SD)

163.67 ± 31.80

133.33 ± 6.30

-3.09

0.002

HCA duration (min, mean ± SD)

44.44 ± 3.65

27.08 ± 3.20

13.38

< 0.001

Erythrocyte (U, mean ± SD)

4.17 ± 1.47

2.92 ± 1.78

2.10

0.045

Plasma (U, mean ± SD)

8.83 ± 1.46

6.66 ± 1.09

4.41

< 0.001

Platelet [U, median (IQR)]

2.00 (0.00)

2.00 (0.75)

-1.67

0.960

Postoperative information

    

Operative area drainage [mL, median (IQR)]

435.00 (97.50)

427.50 (98.75)

-0.81

0.419

VART (h, mean ± SD)

59.97 ± 32.77

28.38 ± 12.77

-2.39

0.017

CICU stay [h, median (IQR)]

108.00 (78.00)

72.00 (66.00)

-2.08

0.038

ARF (undergoing CRRT) (n, %)

1 (5.56%)

1 (8.33%)

——

1.000

TND (n, %)

9 (50.00%)

1 (8.33%)

——

0.024

PND (n, %)

0

0

——

——

Mortality (n, %)

0

0

——

——

  1. Note: Continuous measurement data, t/Z-values and count data percentage are rounded to two decimal places. P-values are rounded to three decimal places. CRRT: continuous renal replacement therapy; TND: temporary neurological dysfunction; PND: permanent neurological deficit.